ARCHIVES

ODAC Endorses Tamoxifen Trial, With Modification to Ensure Enrollment of Women At Higher Risk

This article is from The Cancer Letter archive.

Vol. 17 No. 31 | August 2, 1991

Download PDF Visit The Full Archive

Related Articles

Abstracts From AACR Annual Meeting

May 28, 1976

Letter: Weinstein’s Former Fellows Express “Shock” At Allegations

December 1, 1995

FDA Approves Afinitor For pNET; No Word On Sutent For Same Use

May 6, 2011

NCI Program Review: Report calls For Two Types Of Centers: Comprehensive And All Others

October 18, 1996

Fred Hutchinson Director Lee Hartwell To Retire Next Year; Board Begins Search

July 3, 2009

R01 and P01 Grants Will No Longer Support Phase III Clinical Trials

July 25, 2013